BEIJING, March 21, 2011 /PRNewswire/ -- Varian Medical Systems, Inc. (NYSE: VAR), the world's leading manufacturer of medical technology for treating cancer with radiotherapy, will showcase the company's new TrueBeam™ system for image-guided radiotherapy and radiosurgery at the 23rd International Medical Instruments and Equipment Exhibition in Beijing (ChinaMed), March 25-27, 2011.
TrueBeam was designed from the ground up to treat tumors with unprecedented speed and accuracy — including tumors that move during treatment as the patient breathes in and out. Designed to advance the treatment of lung, breast, prostate, head and neck, and other types of cancer, TrueBeam features a multitude of technical innovations that dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. With its High Intensity Mode, TrueBeam can deliver very high doses quickly and accurately, more than twice as fast as earlier generations of technology.
"The TrueBeam system was first introduced in the United States last April, and this will be the company's first time showing it to medical professionals in China," said Ling Zhang, business marketing manager for Varian Medical Systems. "We are very excited about the opportunity to demonstrate the capabilities of this high-powered cancer fighting machine."
Varian will also highlight the company's X-ray products in the ChinaMed exhibit. These include new technically advanced X-ray tubes and flat panel detectors developed to work together to improve image quality, increase throughput, and reduce the overall cost per procedure. "With our expanded inventory and product support services in our Beijing facility, our customers will be able to take full advantage of the benefits of digital radiology," said Hsiao-Li Pan, manager of Varian's X-Ray Products business in China.
New Technology Seminar
In addition, Varian will officially introduce TrueBeam in China at a new technology seminar on the afternoon of March 25, 2011, in front of some sixty guests from the 25 top hospitals in China. Speakers will include Joshua Lawson, M.D., radiation oncologist at the University of California, San Diego Medical Center, and Joseph Ting, PhD, chief medical physicist at the MIMA Cancer Center in Melbourne, Florida. Dr. Lawson will speak about the clinical advantages of the TrueBeam system. Dr. Ting's talk will focus on the system's High Intensity Mode, which significantly reduces treatment time, making it possible to treat some cancers that would not have been considered treatable before.
"Varian is pleased to showcase this new world-class solution at ChinaMed this year,” said Thomas P. Duffy, Varian's vice president of sales and marketing for the Asia Pacific region. "Early adopters from around the world, like Dr. Lawson and Dr. Ting, are using TrueBeam to deliver precise image-guided treatments, providing cancer patients with access to highly personalized, advanced treatment options.”
ABOUT VARIAN MEDICAL SYSTEMS
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,400 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. The company's center in Beijing encompasses oncology equipment manufacturing operations, an educational center for radiotherapy clinical professionals, a customer service center, and X-ray Products assembly and service. For more information, visit http://www.varian.com.
SOURCE Varian Medical Systems, Inc.